Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Caroline Helwick

Caroline Helwick

Freelance Medical Writer at The ASCO Post

Contact this person
Email address
c*****@*******.comGet email address
Influence score
21
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

ascopost.com

In Extensive-Stage Small Cell Lung Cancer Novel Maintenance Regimen Boosts Overall Survival

The phase Ib DeLLphi-303 trial has reported overall survival data for a novel maintenance regimen in extensive-stage small cell lung cancer following first-line chemoimmunotherapy. Patients treated wi...
about 1 month ago
ascopost.com

In Extensive-Stage Small Cell Lung Cancer Novel Maintenance Regimen...

The phase Ib DeLLphi-303 trial has reported overall survival data for a novel maintenance regimen in extensive-stage small cell lung cancer following first-line chemoimmunotherapy. These findings were...
2 months ago
ascopost.com

Smoldering Multiple Myeloma: How the Guidance Is Changing

Clinical trials have sought to determine the benefit of treating the precursors of multiple myeloma, but as the phenotypes and genomics of this entity are becoming better delineated, the wisdom of ear...
3 months ago
ascopost.com

Experimental Approach to Graft-vs-Host Disease Prophylaxis Offers A...

Prevention of graft-vs-host disease was far superior with a cyclophosphamide/cyclosporin-based regimen than with standard prophylaxis in patients receiving a matched-sibling donor stem cell transplant...
3 months ago
ascopost.com

Smoldering Multiple Myeloma: How the Guidance Is Changing

Smoldering Multiple Myeloma: How the Guidance Is Changing
4 months ago
ascopost.com

Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refr...

Combining the CD79b-directed antibody-drug conjugate polatuzumab vedotin-piiq with rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved survival outcomes in patients with transplan...
4 months ago
ascopost.com

Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refr...

Combining the CD79b-directed antibody-drug conjugate polatuzumab vedotin-piiq with rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved survival outcomes in patients with transplan...
4 months ago
ascopost.com

Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refr...

Combining the CD79b-directed antibody-drug conjugate polatuzumab vedotin-piiq with rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved survival outcomes in patients with transplan...
4 months ago
ascopost.com

A Potential New Standard of Care in Gastric or Gastroesophageal Jun...

In patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma, perioperative treatment with the checkpoint inhibitor durvalumab in combination with standard chemotherapy signif...
4 months ago
ascopost.com

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mut...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer
5 months ago
ascopost.com

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K-Muta...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K-Mutated Colorectal Cancer
5 months ago